Insider · CIK 0001855608
Hannah Valantine
Files at CDNA (CareDx, Inc.), PACB (PACIFIC BIOSCIENCES OF CALIFORNIA, INC.), BBIO (BridgeBio Pharma, Inc.). First filing Mar 10, 2025, latest Jun 30, 2025.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
BBIO: BridgeBio Pharma, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
CDNA: CareDx, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | BridgeBio Pharma, Inc. | $207k 4,707 shares | -48% | +102% from low0% from high | |
| 28Weak | BBIObuy BridgeBio Pharma, Inc. | $30k 2,338 shares | - | - | |
| 30Weak | BBIObuy BridgeBio Pharma, Inc. | $25k 1,752 shares | +114% | - | |
| 27Weak | CareDx, Inc. | $203k 10,570 shares | -21% | +34% from low-41% from high | |
| 19Weak | BridgeBio Pharma, Inc. | $172k 4,292 shares | -71% | +79% from low0% from high | |
| 31Weak | BridgeBio Pharma, Inc. | $419k 12,875 shares | -88% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 26, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock | -876 | $44.11 | $39k | 9,007 | Jun 30, 2025 |
| Dec 28, 2021 | BBIO BridgeBio Pharma, Inc. | POpen-market purchase Common Stock | +1,542 | $12.68 | $20k | 1,542 | Jun 30, 2025 |
| Dec 29, 2021 | BBIO BridgeBio Pharma, Inc. | POpen-market purchase Common Stock | +1,752 | $14.24 | $25k | 3,294 | Jun 30, 2025 |
| Jun 26, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock | -1,542 | $44.01 | $68k | 7,465 | Jun 30, 2025 |
| Dec 28, 2021 | BBIO BridgeBio Pharma, Inc. | POpen-market purchase Common Stockindirect: By Spouse | +796 | $13.16 | $10k | 2,687 | Jun 30, 2025 |
| Jun 26, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Spouse | -398 | $44.13 | $18k | 2,289 | Jun 30, 2025 |
| Jun 26, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Spouse | -1,891 | $44.03 | $83k | 398 | Jun 30, 2025 |
| Jun 20, 2025 | BBIO BridgeBio Pharma, Inc. | AGrant or award Common Stock | +6,589 | $0.00 | $0 | 8,353 | Jun 24, 2025 |
| Jun 20, 2025 | BBIO BridgeBio Pharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +8,425 | $0.00 | $0 | 8,425 | Jun 24, 2025 |
| Jun 18, 2025 | CDNA CareDx, Inc. | SOpen-market sale Common Stock10b5-1 | -10,570 | $19.16 | $203k | 38,994 | Jun 23, 2025 |
| Jun 13, 2025 | CDNA CareDx, Inc. | AGrant or award Common Stock | +12,103 | $0.00 | $0 | 49,564 | Jun 17, 2025 |
| Jun 10, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Common Stock10b5-1 | +4,292 | $16.75 | $72k | 6,056 | Jun 11, 2025 |
| Jun 10, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -4,292 | $40.00 | $172k | 1,764 | Jun 11, 2025 |
| Jun 10, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -4,292 | $0.00 | $0 | 34,334 | Jun 11, 2025 |
| Jun 4, 2025 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | AGrant or award Stock Option (right to buy)derivative | +65,000 | $0.00 | $0 | 65,000 | Jun 6, 2025 |
| Mar 6, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Common Stock10b5-1 | +12,875 | $16.75 | $216k | 14,639 | Mar 10, 2025 |
| Mar 6, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -12,875 | $32.58 | $419k | 1,764 | Mar 10, 2025 |
| Mar 6, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -12,875 | $0.00 | $0 | 38,626 | Mar 10, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.